Thymalin exerts its immunomodulatory effects primarily through the activation of T lymphocytes and the differentiation of hematopoietic stem cells, enhancing the expression of CD28 while reducing CD44 and CD117 markers. The KE dipeptide stimulates cellular immunity by activating macrophages and lymphocytes, while the EW dipeptide inhibits ACE2, potentially modulating the renin-angiotensin system and influencing the inflammatory response via the NF-κB signaling pathway. Although these mechanisms suggest a role in regulating cytokine production and immune responses, the precise molecular interactions and pathways involved remain to be fully elucidated.